Janus Henderson Group PLC Buys 535,986 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Janus Henderson Group PLC increased its position in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 7,753.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 542,899 shares of the technology company's stock after buying an additional 535,986 shares during the quarter. Janus Henderson Group PLC owned about 2.70% of Simulations Plus worth $15,141,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Proficio Capital Partners LLC purchased a new stake in shares of Simulations Plus in the fourth quarter valued at about $719,000. JPMorgan Chase & Co. boosted its holdings in Simulations Plus by 106.0% during the third quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock worth $1,517,000 after purchasing an additional 24,371 shares during the last quarter. Sei Investments Co. purchased a new position in shares of Simulations Plus in the 4th quarter worth approximately $330,000. Tributary Capital Management LLC boosted its stake in shares of Simulations Plus by 21.7% in the 4th quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company's stock worth $11,047,000 after buying an additional 70,526 shares during the last quarter. Finally, AlphaQuest LLC grew its holdings in shares of Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after acquiring an additional 2,243 shares in the last quarter. Institutional investors own 78.08% of the company's stock.

Insider Transactions at Simulations Plus

In related news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director now owns 3,344,157 shares of the company's stock, valued at approximately $112,062,701.07. This represents a 0.59% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 19.40% of the company's stock.

Analysts Set New Price Targets

Several research analysts have weighed in on SLP shares. StockNews.com raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. KeyCorp lifted their target price on Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 16th. Two analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $50.00.

Simulations Plus Trading Down 2.5%

Shares of SLP stock traded down $0.80 on Wednesday, hitting $31.30. 179,880 shares of the stock were exchanged, compared to its average volume of 213,093. The firm's 50 day moving average is $29.28 and its two-hundred day moving average is $30.32. Simulations Plus, Inc. has a one year low of $23.01 and a one year high of $50.98. The firm has a market capitalization of $629.37 million, a PE ratio of 77.58 and a beta of 1.10.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The company had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. During the same period in the prior year, the company posted $0.20 EPS. Simulations Plus's revenue was up 22.5% compared to the same quarter last year. On average, sell-side analysts expect that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.